Rationale for targeted therapies in hepatocellular carcinoma

ISSN： 1776-2596

Source： Targeted Oncology, Vol.3, Iss.2, 2008-04, pp. : 81-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted therapies in bronchioloalveolar carcinoma

By Scagliotti Giorgio

Targeted Oncology, Vol. 3, Iss. 3, 2008-07 ,pp. : 197-204

Springer Publishing Company

Access to resources Recommend Favorite

Systemic therapies in hepatocellular carcinoma: present and future

By Bertino Gaetano Di Carlo Isidoro Ardiri Annalisa Calvagno Giuseppe Stefano Demma Shirin Malaguarnera Giulia Bertino Nicoletta Malaguarnera Mariano Toro Adriana Malaguarnera Michele

Future Oncology, Vol. 9, Iss. 10, 2013-10 ,pp. : 1533-1548

Future Medicine

Access to resources Recommend Favorite

Update on targeted therapies for small cell carcinoma of the lung

By Griffiths Richard

Targeted Oncology, Vol. 3, Iss. 3, 2008-07 ,pp. : 205-215

Springer Publishing Company

Access to resources Recommend Favorite

Targeted Therapies in the Treatment of Advanced Renal Cell Carcinoma

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 2, 2009-06 ,pp. : 146-156

Bentham Science Publishers

Access to resources Recommend Favorite

EpCAM-Targeted Therapy for Human Hepatocellular Carcinoma

By Ogawa Kousuke Tanaka Shinji Matsumura Satoshi Murakata Ayano Ban Daisuke Ochiai Takanori Irie Takumi Kudo Atsushi Nakamura Noriaki Tanabe Minoru Arii Shigeki

Annals of Surgical Oncology, Vol. 21, Iss. 4, 2014-04 ,pp. : 1314-1322

Springer Publishing Company

Access to resources Recommend Favorite